How to buy DiaMedica Therapeutics stock | $7.41

DiaMedica Therapeutics Inc is a biotechnology business based in the US. DiaMedica Therapeutics shares (DMAC) are listed on the NASDAQ and all prices are listed in US Dollars. DiaMedica Therapeutics employs 10 staff and has a market cap (total outstanding shares value) of 0.00.

DiaMedica Therapeutics stock price (NASDAQ: DMAC)

Use our graph to track the performance of DMAC stocks over time.

DiaMedica Therapeutics shares at a glance

• Key figures

Information last updated 2021-07-31.

Latest market close	$7.41
52-week range	$3.30 - $10.88
50-day moving average	$5.32
200-day moving average	$8.01
Wall St. target price	$23.50
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.90

Buy DiaMedica Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy DiaMedica Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of DiaMedica Therapeutics Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

DiaMedica Therapeutics price performance over time

Historical closes compared with the close of $7.41 from 2021-05-28

1 week (2021-07-22)	N/A
1 month (2021-07-02)	75.59%
3 months (2021-04-30)	-21.17%
6 months (2021-01-29)	N/A

1 year (2020-07-29)	N/A
2 years (2019-07-29)	N/A
3 years (2018-07-29)	N/A
5 years (2016-07-29)	N/A

DiaMedica Therapeutics financials

Gross profit TTM	$0
Return on assets TTM	-44.92%
Return on equity TTM	-73.98%
Profit margin	0%
Book value	$1.23
Market capitalisation	$64.8 million

TTM: trailing 12 months

Shorting DiaMedica Therapeutics shares

There are currently 72,751 DiaMedica Therapeutics shares held short by investors – that's known as DiaMedica Therapeutics's "short interest". This figure is 47.6% down from 138,725 last month.

There are a few different ways that this level of interest in shorting DiaMedica Therapeutics shares can be evaluated.

DiaMedica Therapeutics's "short interest ratio" (SIR)

DiaMedica Therapeutics's "short interest ratio" (SIR) is the quantity of DiaMedica Therapeutics shares currently shorted divided by the average quantity of DiaMedica Therapeutics shares traded daily (recently around 559623.07692308). DiaMedica Therapeutics's SIR currently stands at 0.13. In other words for every 100,000 DiaMedica Therapeutics shares traded daily on the market, roughly 130 shares are currently held short.

However DiaMedica Therapeutics's short interest can also be evaluated against the total number of DiaMedica Therapeutics shares, or, against the total number of tradable DiaMedica Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case DiaMedica Therapeutics's short interest could be expressed as 0% of the outstanding shares (for every 100,000 DiaMedica Therapeutics shares in existence, roughly 0 shares are currently held short) or 0.0042% of the tradable shares (for every 100,000 tradable DiaMedica Therapeutics shares, roughly 4 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against DiaMedica Therapeutics.

Find out more about how you can short DiaMedica Therapeutics stock.

DiaMedica Therapeutics share dividends

We're not expecting DiaMedica Therapeutics to pay a dividend over the next 12 months.

Have DiaMedica Therapeutics's shares ever split?

DiaMedica Therapeutics's shares were split on a 1:20 basis on 14 November 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your DiaMedica Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for DiaMedica Therapeutics shares which in turn could have impacted DiaMedica Therapeutics's share price.

DiaMedica Therapeutics share price volatility

Over the last 12 months, DiaMedica Therapeutics's shares have ranged in value from as little as $3.3 up to $10.88. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while DiaMedica Therapeutics's is 2.3852. This would suggest that DiaMedica Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

DiaMedica Therapeutics overview

DiaMedica Therapeutics Inc. , a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. Its lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which has completed Phase Ib clinical trials for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase II REMEDY trials for the treatment of patients with acute ischemic stroke. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc.

Frequently asked questions

What percentage of DiaMedica Therapeutics is owned by insiders or institutions?
Currently 7.897% of DiaMedica Therapeutics shares are held by insiders and 33.296% by institutions. How many people work for DiaMedica Therapeutics?
Latest data suggests 10 work at DiaMedica Therapeutics. When does the fiscal year end for DiaMedica Therapeutics?
DiaMedica Therapeutics's fiscal year ends in December. Where is DiaMedica Therapeutics based?
DiaMedica Therapeutics's address is: Two Carlson Parkway, Minneapolis, MN, United States, 55447 What is DiaMedica Therapeutics's ISIN number?
DiaMedica Therapeutics's international securities identification number is: CA25253X2077 What is DiaMedica Therapeutics's CUSIP number?
DiaMedica Therapeutics's Committee on Uniform Securities Identification Procedures number is: 25253X207